FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

RemedyRepack Lisinopril/HCTZ 20mg/12 Recall

Lisinopril/HCTZ 20mg/12

RemedyRepack Inc. · Indiana, PA

Risk level
Class II
Reported by FDA
Mar 25, 2020
Recall ID
D-1030-2020
Check your lot numberHow we source this data

Summary

RemedyRepack recalled Lisinopril/HCTZ 20mg/12 starting Aug 5, 2019. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-1030-2020 on Mar 25, 2020. Reason: Presence of Foreign Tablets/Capsules: This is a spin-off recall of D-1581-2019 due to a product complaint where one of Lupin's Fenofibrate 145mg was observed in the 500 s count product bottle. Status: Terminated.

Why it was recalled

Presence of Foreign Tablets/Capsules: This is a spin-off recall of D-1581-2019 due to a product complaint where one of Lupin's Fenofibrate 145mg was observed in the 500 s count product bottle.

Product description

Lisinopril/HCTZ 20mg/12.5mg Tablet, QTY: 30 tablets per blister card, MFG: Lupin Pharma Baltimore, MD 21202, NDC 68180-0519-02 (Original NDC of 500 count bottle); 70518-0382-03 (Repackaged NDC for blister cards).

Lot numbers, UPCs & expiration codes

Lot #: J0322819-091418, Exp: 09/30/2019

Where it was sold

PA

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1030-2020
Classification
Class II
Status
Terminated
Recall initiated
Aug 5, 2019
FDA report date
Mar 25, 2020
Quantity
480 tablets
Recall type
Voluntary: Firm initiated
Recalling firm
RemedyRepack Inc.

Original FDA data

Every field from FDA enforcement report D-1030-2020, exactly as published.

Show all FDA fields
City
Indiana
State
PA
Status
Terminated
Country
United States
Event ID
83645
Address
625 Kolter Dr Ste 4
Code information
Lot #: J0322819-091418, Exp: 09/30/2019
Postal code
15701-3571
Report date
Mar 25, 2020
Product type
Drugs
Recall number
D-1030-2020
Classification
Class II
Recalling firm
RemedyRepack Inc.
Product quantity
480 tablets
Termination date
Jun 2, 2023
Reason for recall
Presence of Foreign Tablets/Capsules: This is a spin-off recall of D-1581-2019 due to a product complaint where one of Lupin's Fenofibrate 145mg was observed in the 500 s count product bottle.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Lisinopril/HCTZ 20mg/12.5mg Tablet, QTY: 30 tablets per blister card, MFG: Lupin Pharma Baltimore, MD 21202, NDC 68180-0519-02 (Original NDC of 500 count bottle); 70518-0382-03 (Repackaged NDC for blister cards).
Distribution pattern
PA
Recall initiation date
Aug 5, 2019
Initial firm notification
Letter
Center classification date
Mar 16, 2020

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1030-2020, published Mar 25, 2020. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls